Modern Healthcare Technology Holdings Limited
Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, Mainland China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skincare and Wellness Products. It offers beauty and facial services; aesthetics services, such as skincare treatment, professional consultation, skin care… Read more
Modern Healthcare Technology Holdings Limited (M3L) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2022: 0.114x
Based on the latest financial reports, Modern Healthcare Technology Holdings Limited (M3L) has a cash flow conversion efficiency ratio of 0.114x as of September 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€29.85 Million) by net assets (€262.07 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Modern Healthcare Technology Holdings Limited - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Modern Healthcare Technology Holdings Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Modern Healthcare Technology Holdings Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Modern Healthcare Technology Holdings Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Correlate Infrastructure Partners Inc
OTCQB:CIPI
|
-0.123x |
|
Topvision Eye Specialist Berhad
KLSE:0332
|
N/A |
|
Berto Acquisition Corp. Warrant
NASDAQ:TACOW
|
0.000x |
|
ORACLE
BE:ORC
|
0.659x |
|
Carmat SA
F:CXT
|
0.300x |
|
Novolog Pharm-Up 1966 Ltd
TA:NVLG
|
0.040x |
|
Urban-Gro Inc
NASDAQ:UGRO
|
0.056x |
|
Coca Cola HBC AG
LSE:CCH
|
0.256x |
Annual Cash Flow Conversion Efficiency for Modern Healthcare Technology Holdings Limited (2014–2025)
The table below shows the annual cash flow conversion efficiency of Modern Healthcare Technology Holdings Limited from 2014 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | €191.20 Million | €151.09 Million | 0.790x | +95.29% |
| 2024-03-31 | €194.39 Million | €78.66 Million | 0.405x | -41.00% |
| 2023-03-31 | €203.88 Million | €139.82 Million | 0.686x | +198.35% |
| 2022-03-31 | €223.21 Million | €51.31 Million | 0.230x | -45.65% |
| 2021-03-31 | €292.89 Million | €123.88 Million | 0.423x | +0.67% |
| 2020-03-31 | €152.11 Million | €63.91 Million | 0.420x | +134.15% |
| 2019-03-31 | €186.90 Million | €33.53 Million | 0.179x | +160.99% |
| 2018-03-31 | €88.43 Million | €-26.02 Million | -0.294x | -0.97% |
| 2017-03-31 | €125.44 Million | €-36.55 Million | -0.291x | -241.97% |
| 2016-03-31 | €72.97 Million | €14.98 Million | 0.205x | -12.98% |
| 2015-03-31 | €171.17 Million | €40.37 Million | 0.236x | -59.42% |
| 2014-03-31 | €145.31 Million | €84.45 Million | 0.581x | -- |